Neuroanatomical correlates of apathy in Parkinson's disease: A magnetic resonance imaging study using voxel-based morphometry

Movement Disorders

Volumn 25, Issue 14, 2010, Pages 2318-2325

  Reijnders, Jennifer S A M ^a   Scholtissen, Bart ^b   Weber, Wim E J ^a   Aalten, Pauline ^a   Verhey, Frans R J ^a   Leentjens, Albert F G ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Apathy; Magnetic resonance imaging; Parkinson's disease; Voxel based morphometry

Indexed keywords

ADULT; AGED; APATHY; ARTICLE; BRAIN CORTEX; BRAIN REGION; CINGULATE GYRUS; COGNITION; DEPRESSION; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; NEUROANATOMY; NEUROPSYCHIATRY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; VOXEL BASED MORPHOMETRY;

ADULT; AGED; AGED, 80 AND OVER; APATHY; BRAIN MAPPING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 77958568569     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23268     Document Type: Article

References (50)

1. Leentjens AFG, Dujardin K, Marsh L, et al. Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2008; 23: 2004-2014.
2. Robert P, Onyike CU, Leentjens AF, et al. Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry 2009; 24: 98-104.
3. Starkstein SE, Leentjens AF. The nosological position of apathy in clinical practice. J Neurol Neurosurg Psychiatry 2008; 79: 1088-1092.
4. Marin RS. Differential diagnosis and classification of apathy. Am J Psychiatry 1990; 147: 22-30.
5. Isella V, Melzi P, Grimaldi M, et al. Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease. Mov Disord 2002; 17: 366-371.
6. Kirsch-Darrow L, Fernandez HH, Marsiske M, Okun MS, Bowers D. Dissociating apathy and depression in Parkinson's disease. Neurology 2006; 67: 33-38.
7. Pedersen KF, Larsen JP, Alves G, Aarsland D. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study. Parkinsonism Relat Disord 2009; 15: 295-299.
8. Dujardin K, Sockeel P, Devos D, et al. Characteristics of apathy in Parkinson's disease. Mov Disord 2007; 22: 778-784.
9. Pluck GC, Brown RG. Apathy in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002; 73: 636-642.
10. Aarsland D, Larsen JP, Lim NG, et al. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 67: 492-496.
11. Pedersen KF, Alves G, Aarsland D, Larsen JP. Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study. J Neurol Neurosurg Psychiatry 2009; 80: 1279-1282.
12. Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 2006; 16: 916-928.
13. Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005; 128(Part 6): 1314-1322.
14. Le Jeune F, Drapier D, Bourguignon A, et al. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology 2009; 73: 1746-1751.
15. De Rijk MC, Rocca WA, Anderson DW, Melcon MO, Breteler MMB, Maraganore DM. A population perspective on diagnostic criteria for Parkinson's disease. Neurology 1997; 48: 1277-1281.
16. Folstein MF, Folstein SE, McHugh PR. Mini Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
17. Fahn S, Elton RL; members of the UPDRS committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, editors. Recent developments in Parkinson's disease. New Jersey: McMillan Health Care; 1987. p 153-163.
18. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-442.
19. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
20. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-2314.
21. Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 1997; 48( 5 Suppl 6): S10-S16.
22. Clarke DE, Reekum R, Simard M, Streiner DL, Freedman M, Conn D. Apathy in dementia: an examination of the psychometric properties of the apathy evaluation scale. J Neuropsychiatry Clin Neurosci 2007; 19: 57-64.
23. Marin RS, Biedrycki RC, Firiciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 1991; 38: 143-162.
24. Sockeel P, Dujardin K, Devos D, Deneve C, Destee A, Defebvre L. The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77: 579-584.
25. Zahodne LB, Young S, Kirsch-Darrow L, et al. Examination of the Lille Apathy Rating Scale in Parkinson disease. Mov Disord 2009; 24: 677-683.
26. Derix MM, Hofstede AB, Teunisse S, Hijdra A, Walstra GJ, Weinstein HC, van Gool WA. [CAMDEX-N: the Dutch version of the Cambridge Examination for Mental Disorders of the Elderly with automatic data processing]. Tijdschrift voor Gerontologie en Geriatrie 1991; 22: 143-150.
27. Mazziotta J, Toga A, Evans A, et al. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond 2001; 356: 1293-1322.
28. Karas GB, Scheltens P, Rombouts SA, et al. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage 2004; 23: 708-716.
29. Woods RP. Characterizing volume and surface deformations in an atlas framework: theory, applications, and implementation. Neuroimage 2003; 18: 769-788.
30. De Bie SE. Standaardvragen 1987: voorstellen voor uniformering van vraagstellingen naar achtergrondkenmerken en interviews. Leiden, The Netherlands: Leiden University Press; 1987.
31. Bruen PD, McGeown WJ, Shanks MF, Venneri A. Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. Brain 2008; 131(Part 9): 2455-2463.
32. Apostolova LG, Akopyan GG, Partiali N, et al. Structural correlates of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord 2007; 24: 91-97.
33. Rosen HJ, Allison SC, Schauer GF, Gorno-Tempini ML, Weiner MW, Miller BL. Neuroanatomical correlates of behavioural disorders in dementia. Brain 2005; 128(Part 11): 2612-2625.
34. David R, Koulibaly M, Benoit M, et al. Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases A SPECT study with partial volume effect correction. Clin Neurol Neurosurg 2008; 110: 19-24.
35. Lanctot KL, Moosa S, Herrmann N, et al. A SPECT study of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord 2007; 24: 65-72.
36. Benoit M, Koulibaly PM, Migneco O, Darcourt J, Pringuey DJ, Robert PH. Brain perfusion in Alzheimer's disease with and without apathy: a SPECT study with statistical parametric mapping analysis. Psychiatry Res 2002; 114: 103-111.
37. Marshall GA, Fairbanks LA, Tekin S, Vinters HV, Cummings JL. Neuropathologic correlates of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord 2006; 21: 144-147.
38. Lavretsky H, Ballmaier M, Pham D, Toga A, Kumar A. Neuroanatomical characteristics of geriatric apathy and depression: a magnetic resonance imaging study. Am J Geriatr Psychiatry 2007; 15: 386-394.
39. Damasio AR. The somatic marker hypothesis and the possible functions of the prefrontal cortex. Philos Trans R Soc Lond 1996; 351: 1413-1420.
40. Davidson RJ, Irwin W. The functional neuroanatomy of emotion and affective style. Trends Cogn Sci 1999; 3: 11-21.
41. Kjaer TW, Nowak M, Lou HC. Reflective self-awareness and conscious states: PET evidence for a common midline parietofrontal core. Neuroimage 2002; 17: 1080-1086.
42. Lou HC, Luber B, Crupain M, et al. Parietal cortex and representation of the mental Self. Proc Natl Acad Sci USA 2004; 101: 6827-6832.
43. Matsui H, Udaka F, Miyoshi T, et al. Frontal assessment battery and brain perfusion image in Parkinson's disease. J Geriatr Psychiatry Neurol 2006; 19: 41-45.
44. Lima CF, Meireles LP, Fonseca R, Castro SL, Garrett C. The Frontal Assessment Battery (FAB) in Parkinson's disease and correlations with formal measures of executive functioning. J Neurol 2008; 255: 1756-1761.
45. Zgaljardic DJ, Borod JC, Foldi NS, et al. Relationship between self-reported apathy and executive dysfunction in nondemented patients with Parkinson disease. Cogn Behav Neurol 2007; 20: 184-192.
46. Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R, Dubois B. Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia 2002; 40: 2257-2267.
47. Leentjens AFG, Koester J, Fruh B, Shephard DT, Barone P, Houben JJ. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies. Clin Ther 2009; 31: 89-98.
48. Bookstein FL. "Voxel-based morphometry" should not be used with imperfectly registered images. Neuroimage 2001; 14: 1454-1462.
49. Ashburner J, Friston KJ. Why voxel-based morphometry should be used. Neuroimage 2001; 14: 1238-1243.
50. Karas G, Sluimer J, Goekoop R, et al. Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease. AJNR Am J Neuroradiol 2008; 29: 944-949.